1.Surveillance of bacterial resistance in tertiary hospitals across China:results of CHINET Antimicrobial Resistance Surveillance Program in 2022
Yan GUO ; Fupin HU ; Demei ZHU ; Fu WANG ; Xiaofei JIANG ; Yingchun XU ; Xiaojiang ZHANG ; Fengbo ZHANG ; Ping JI ; Yi XIE ; Yuling XIAO ; Chuanqing WANG ; Pan FU ; Yuanhong XU ; Ying HUANG ; Ziyong SUN ; Zhongju CHEN ; Jingyong SUN ; Qing CHEN ; Yunzhuo CHU ; Sufei TIAN ; Zhidong HU ; Jin LI ; Yunsong YU ; Jie LIN ; Bin SHAN ; Yunmin XU ; Sufang GUO ; Yanyan WANG ; Lianhua WEI ; Keke LI ; Hong ZHANG ; Fen PAN ; Yunjian HU ; Xiaoman AI ; Chao ZHUO ; Danhong SU ; Dawen GUO ; Jinying ZHAO ; Hua YU ; Xiangning HUANG ; Wen'en LIU ; Yanming LI ; Yan JIN ; Chunhong SHAO ; Xuesong XU ; Wei LI ; Shanmei WANG ; Yafei CHU ; Lixia ZHANG ; Juan MA ; Shuping ZHOU ; Yan ZHOU ; Lei ZHU ; Jinhua MENG ; Fang DONG ; Zhiyong LÜ ; Fangfang HU ; Han SHEN ; Wanqing ZHOU ; Wei JIA ; Gang LI ; Jinsong WU ; Yuemei LU ; Jihong LI ; Qian SUN ; Jinju DUAN ; Jianbang KANG ; Xiaobo MA ; Yanqing ZHENG ; Ruyi GUO ; Yan ZHU ; Yunsheng CHEN ; Qing MENG ; Shifu WANG ; Xuefei HU ; Wenhui HUANG ; Juan LI ; Quangui SHI ; Juan YANG ; Abulimiti REZIWAGULI ; Lili HUANG ; Xuejun SHAO ; Xiaoyan REN ; Dong LI ; Qun ZHANG ; Xue CHEN ; Rihai LI ; Jieli XU ; Kaijie GAO ; Lu XU ; Lin LIN ; Zhuo ZHANG ; Jianlong LIU ; Min FU ; Yinghui GUO ; Wenchao ZHANG ; Zengguo WANG ; Kai JIA ; Yun XIA ; Shan SUN ; Huimin YANG ; Yan MIAO ; Mingming ZHOU ; Shihai ZHANG ; Hongjuan LIU ; Nan CHEN ; Chan LI ; Jilu SHEN ; Wanqi MEN ; Peng WANG ; Xiaowei ZHANG ; Yanyan LIU ; Yong AN
Chinese Journal of Infection and Chemotherapy 2024;24(3):277-286
		                        		
		                        			
		                        			Objective To monitor the susceptibility of clinical isolates to antimicrobial agents in tertiary hospitals in major regions of China in 2022.Methods Clinical isolates from 58 hospitals in China were tested for antimicrobial susceptibility using a unified protocol based on disc diffusion method or automated testing systems.Results were interpreted using the 2022 Clinical &Laboratory Standards Institute(CLSI)breakpoints.Results A total of 318 013 clinical isolates were collected from January 1,2022 to December 31,2022,of which 29.5%were gram-positive and 70.5%were gram-negative.The prevalence of methicillin-resistant strains in Staphylococcus aureus,Staphylococcus epidermidis and other coagulase-negative Staphylococcus species(excluding Staphylococcus pseudintermedius and Staphylococcus schleiferi)was 28.3%,76.7%and 77.9%,respectively.Overall,94.0%of MRSA strains were susceptible to trimethoprim-sulfamethoxazole and 90.8%of MRSE strains were susceptible to rifampicin.No vancomycin-resistant strains were found.Enterococcus faecalis showed significantly lower resistance rates to most antimicrobial agents tested than Enterococcus faecium.A few vancomycin-resistant strains were identified in both E.faecalis and E.faecium.The prevalence of penicillin-susceptible Streptococcus pneumoniae was 94.2%in the isolates from children and 95.7%in the isolates from adults.The resistance rate to carbapenems was lower than 13.1%in most Enterobacterales species except for Klebsiella,21.7%-23.1%of which were resistant to carbapenems.Most Enterobacterales isolates were highly susceptible to tigecycline,colistin and polymyxin B,with resistance rates ranging from 0.1%to 13.3%.The prevalence of meropenem-resistant strains decreased from 23.5%in 2019 to 18.0%in 2022 in Pseudomonas aeruginosa,and decreased from 79.0%in 2019 to 72.5%in 2022 in Acinetobacter baumannii.Conclusions The resistance of clinical isolates to the commonly used antimicrobial agents is still increasing in tertiary hospitals.However,the prevalence of important carbapenem-resistant organisms such as carbapenem-resistant K.pneumoniae,P.aeruginosa,and A.baumannii showed a downward trend in recent years.This finding suggests that the strategy of combining antimicrobial resistance surveillance with multidisciplinary concerted action works well in curbing the spread of resistant bacteria.
		                        		
		                        		
		                        		
		                        	
2. Risk factors of venous thromboembolism and evaluation of existing risk assessment models for predicting venous thromboembolism in medical oncology inpatients
Xue-qian MEN ; He-ming LI ; Qian DONG ; Yuan-he WANG ; Jin ZHOU ; Yan-rong LI ; Jing-dong ZHANG
Chinese Journal of Practical Internal Medicine 2019;39(08):694-697
		                        		
		                        			
		                        			 OBJECTIVE: To investigate the risk factors of venous thrombosis(VTE) and to evaluate the predictive ability of the existing risk assessment models(RAM) in medical oncology inpatients. METHODS: In this study, 252 medical oncology inpatients were divided into study group(63) and control group(189) according to VTE. Logistic regression analysis was performed to identify the risk factors of VTE and to evaluate the predictive ability of KRS and PPS. RESULTS: This study showed that previous VTE, staying in bed≥3 d,platelet count≥350×10~9/L, D-dimer>0.55 mg/L and stage IV cancer were associated with VTE risks(OR=12.149, 3.672, 3.144, 5.263,1.439, 1.382, P<0.05). Furthermore, we performed the risk assessment of VTE according to KRS and PPS respectively. For KRS, in the low-and intermediate-risk subgroup, statistical difference existed between study and control group(P<0.01); but in high-risk subgroup,no significant difference existed between study and control group. For PPS, no significant difference existed between study and control group. CONCLUSION: For the inpatients of medical oncology department, previous VTE, staying in bed≥3 d, platelet count≥350×10~9/L, D-dimer>0.55 mg/L, and stage IV cancer are independent risk factors of VTE. Compared with the limited predictive ability of PPS,KRS can predict VTE very well for low-and intermediate-risk patients. 
		                        		
		                        		
		                        		
		                        	
3.Current status and research progress of cysticercosis
Huan-Zhang LI ; Xin-Zhong ZANG ; Men-Bao QIAN ; Jing-Bo XUE ; Chang-Hai ZHOU ; Ying-Dan CHEN ; Tian TIAN ; Chun-Li CAO ; Shi-Zhu LI
Chinese Journal of Schistosomiasis Control 2018;30(1):99-103
		                        		
		                        			
		                        			Cysticercosis refers to a parasitic infection caused by the larvae of pork tapeworm Taenia solium.It is a parasitic zoonosis and listed by the World Health Organization(WHO)as one of the neglected tropical diseases.Cysticercosis is spread-ing all over the world through globalization and it mainly epidemic in developing countries.In the southwest and minority nation-ality areas of China,as a result of the low level of medical and health care,and the unchangeable diet custom,there are still many cases of cysticercosis,which is manifested as a local high prevalence.Neuroimaging is the preferred method for cysticerco-sis diagnosis,and by using CT and MRI scans it is possible to visualise the infecting cysticerci and assess their number and loca-tion within the central nervous system(CNS).The immunological assay is also required in the diagnosis.At present,the preven-tion and control of cysticercosis is still relatively weak.In this paper,the current status and research progress of cysticercosis are reviewed,and further suggestions on the prevention and control of cysticercosis are put forward.
		                        		
		                        		
		                        		
		                        	
4.Design and implementation of field questionnaire survey system of taeniasis/cysticercosis
Huan-Zhang LI ; Jing-Bo XUE ; Men-Bao QIAN ; Xin-Zhong ZANG ; Shang XIA ; Qiang WANG ; Ying-Dan CHEN ; Shi-Zhu LI
Chinese Journal of Schistosomiasis Control 2018;30(2):211-214,225
		                        		
		                        			
		                        			A taeniasis/cysticercosis information management system was designed to achieve the dynamic monitoring of the epidemic situation of taeniasis/cysticercosis and improve the intelligence level of disease information management.The system in-cludes three layer structures(application layer,technical core layer,and data storage layer)and designs a datum transmission and remote communication system of traffic information tube in Browser/Server architecture.The system is believed to promote disease datum collection.Additionally,the system may provide the standardized data for convenience of datum analysis.
		                        		
		                        		
		                        		
		                        	
5.Novel multiplex primer extension and denaturing high-performance liquid chromatography for genotyping of the deafness gene mutations
Meichao MEN ; Jinjie XUE ; Lu JIANG ; Honghan WANG ; Qian PAN ; Yong FENG
Journal of Central South University(Medical Sciences) 2011;36(11):1079-1084
		                        		
		                        			
		                        			To find a rapid and accurate genotyping method for specific non-syndromic hearing loss (NSHL)-causing gene mutations for disease diagnosis in different ethnic populations.Methods We performed a novel multiplex primer extension (PE) reaction in combination with denaturing high-performance liquid chromatography (DHPLC) to simultaneously detect and genotype the 6 most common mutations in 180 patients with NSHL (GJB2-235delC,GJB2-299delAT,PDS-A2168G,PDS IVS7-2A > G,mtDNA-A1555G,and mtDNA-C1494T) in Chinese population.This method involved the amplification of the target sequence,followed by a purification step,a multiplex PE reaction,and DHPLC analysis performed on the Transgenomic Wave DNA fragment analysis system under fully-denaturing conditions.Results In a blind analysis,this technique successfully and accurately genotyped 100% of the samples simultaneously characterized by direct sequencing.Conclusion Combination of PE and DHPLC is simple,rapid,accurate,and cost-effective for genotyping common disease-causing mutations,including substitutions,insertions,and deletions in NSHL,and may be successfully used in other genetic diseases.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail